Literature DB >> 6199801

Class I antiarrhythmic agents: quinidine, procainamide and N-acetylprocainamide, disopyramide.

D M Roden, R L Woosley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6199801     DOI: 10.1016/0163-7258(83)90012-8

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  5 in total

1.  Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects.

Authors:  Jae-Gook Shin; Won-Ku Kang; Ji-Hong Shon; Million Arefayene; Young-Ran Yoon; Kyung-Ah Kim; Doo-Il Kim; Dong-Soo Kim; Kwang-Hyun Cho; Raymond L Woosley; David A Flockhart
Journal:  Br J Clin Pharmacol       Date:  2006-11-10       Impact factor: 4.335

2.  Lack of interaction between meloxicam and warfarin in healthy volunteers.

Authors:  D Türck; C A Su; G Heinzel; U Busch; E Bluhmki; J Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

Review 3.  Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies.

Authors:  Jordan L Lacoste; Thomas W Szymanski; Juan Carlo Avalon; Galen Kabulski; Utkarsh Kohli; Nassir Marrouche; Atul Singla; Sudarshan Balla; Arshad Jahangir
Journal:  Am J Cardiovasc Drugs       Date:  2022-03-30       Impact factor: 3.283

4.  Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans.

Authors:  L Bergfeldt; K Schenck-Gustafsson; R Dahlqvist
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

5.  Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles.

Authors:  Dominic G Whittaker; Haibo Ni; Alan P Benson; Jules C Hancox; Henggui Zhang
Journal:  Front Physiol       Date:  2017-10-04       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.